Among people with relapsing forms of multiple sclerosis (MS) and highly active disease, Mavenclad (cladribine) treatment resulted in stable or better cognitive function over two years. That’s according to new data from the Phase 4 CLARIFY-MS study (NCT03369665), which also demonstrated that Mavenclad can stabilize employment status for…
Discussion
Living with multiple sclerosis has taught me that some of the hardest symptoms to explain are the ones no one else can see. For me, one of those is itchiness. Not the kind that comes from dry skin or a mosquito bite, but something deeper, more unsettling. It…
Discussion
National Football League player Fernando Mendoza and his family are partnering with the National Multiple Sclerosis Society (NMSS) to fund research and support programs for people with multiple sclerosis (MS). The Mendoza Family Fund builds on the efforts of Mendoza and his family to raise funds and…
Discussion
Medthera has launched WalkPort, a supported walking station designed to help people with mobility difficulties, including those with multiple sclerosis (MS), safely stand and practice walking at home and in clinical settings. The device is now open for reservations, with initial shipments expected to start in August,…
Discussion
Brain inflammation is often viewed as harmful in neurological diseases such as multiple sclerosis (MS), but a new animal study suggests that certain short-lived forms of inflammation may be needed to help the brain repair myelin. This finding may have important implications for understanding the biology of MS…
Get regular updates to your inbox.
